US·Bill·117th Congress
S 2609
Facilitating Innovative Nuclear Diagnostics Act of 2021
Introduced 2021-08-04Last action 2021-08-04 — Read twice and referred to the Committee on Finance.Committee Senate Committee on Finance
Sponsor
⚫
Died in committee
The 117th Congress ended on 2023-01-03. This bill was in committee when the session adjourned and did not advance to enactment.
Legislative Progress
✓
Introduced
✗
In Committee
3
Passed Chamber
4
Enacted / Signed
Action History
Read twice and referred to the Committee on Finance.
2021-08-04 · Senate
Introduced in Senate
2021-08-04 · Library of Congress
Summary
Facilitating Innovative Nuclear Diagnostics Act of 2021
This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2022 and as adjusted based on a specified fee schedule factor in each year thereafter.
Full Bill Text
https://www.congress.gov/bill/117th-congress/s/2609